We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
How to use a think aloud study to evaluate your digital health product.
How to use feedback from marketplace reviews to evaluate your digital health product.
How to use interviews to evaluate your digital health product.
Actions that trial sponsors should consider to build resilience into clinical trial design
Compare different evaluation approaches and choose an appropriate method.
Foresight project looking at how future scientific advances may affect our understanding of addiction and drug use.
How to use a cost consequence analysis to evaluate your digital health product.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
View highlights of some of our most recently published research on this page. You can also download a complete list of our published research.
Information for prospective growers of low THC cannabis (industrial hemp), for the production of seed and fibre only.
Overview of the analysis of novel foods for the presence of cannabidiol
Summary of the government's ongoing programme of work addressing key issues identified by the DCMS Select Committee’s Inquiry into the Economics of Music Streaming, including an indicative timeline for upcoming milestones.
This factsheet outlines the domestic control measures that apply to cannabis, cannabidiol (CBD) and controlled cannabinoids.
An assessment of the impact of rescheduling CBPMs to Schedule 2 under the Misuse of Drugs Regulations 2001 (MDR) and recommendations to mitigate the issues identified.
This collection brings together all documents in the Employment Relations Research Series.
Technical advice and guidance for licence holders.
Research on the Green Deal assessment experience and what households have done and plan to do since having the assessment.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).